Presentation is loading. Please wait.

Presentation is loading. Please wait.

Global Systemic Psoriasis Therapeutics Market 2016-2020 www.rnrmarketresearch.com WEBSITE Single User License: US$ 2500 No of Pages: 88 Corporate User.

Similar presentations


Presentation on theme: "Global Systemic Psoriasis Therapeutics Market 2016-2020 www.rnrmarketresearch.com WEBSITE Single User License: US$ 2500 No of Pages: 88 Corporate User."— Presentation transcript:

1 Global Systemic Psoriasis Therapeutics Market 2016-2020 www.rnrmarketresearch.com WEBSITE Single User License: US$ 2500 No of Pages: 88 Corporate User License: US$ 4000

2 Global Systemic Psoriasis Therapeutics Market 2016-2020  Global Systemic Psoriasis Therapeutics Market 2016-2020 reports considers the revenue generated from the from the sales of branded, generic, and off-label drugs used to treat psoriasis. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period. The report covers the present scenario and the growth prospects of the global systemic psoriasis therapeutics market for 2016-2020.  The analysts forecast the global systemic psoriasis therapeutics market to grow at a CAGR of 9.41% during the period 2016-2020. Psoriasis is a commonly diagnosed immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes a build-up of red, thick white, or silvery patches. It modifies the normal cell cycle of the skin such that new cells move to the surface of the skin quickly to form patches called plaques. These plaques are commonly found on the knees, elbows, scalp, hand and feet. The condition mostly occurs among adults (18 years-35 years), but can also be seen in adolescents (12 years-18 years) and children (under 10 years). View Complete Report @ http://www.rnrmarketresearch.com/global-systemic-psoriasis-therapeutics-market- 2016-2020-market-report.htmlhttp://www.rnrmarketresearch.com/global-systemic-psoriasis-therapeutics-market- 2016-2020-market-report.html

3 Global Systemic Psoriasis Therapeutics Market 2016-2020  Psoriasis is more prevalent among Caucasians compared to African-Americans. According to a World Health Organization (WHO) document of 2015, the global prevalence of psoriasis is approximately 2%-3%. However, it is approximately 4.6% in developed countries. In addition, the risk of an individual getting diagnosed with psoriasis is 41% if both parents have psoriasis, 14% in case one parent is affected, and 6% if a sibling has psoriasis.  The report, Global Systemic Psoriasis Therapeutics Market 2016-2020, has been prepared based on an in- depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors : AbbVie, Johnson & Johnson, Celgene, Amgen, and Pfizer. Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=635370 http://www.rnrmarketresearch.com/contacts/purchase?rname=635370

4 Global Systemic Psoriasis Therapeutics Market 2016-2020  Other prominent vendors : AbGenomics, Almirall, Anacor Pharmaceuticals, ApoPharma, Astellas Pharma, AstraZeneca, Aurinia Pharmaceuticals, Biocon, Biogen Idec, Biotest, Boehringer Ingelheim, Bristol-Myers Squibb, Can-Fite BioPharma, Cellceutix Corporation, Coherus Biosciences, Creabilis, Crescendo Biologics, Delenex Therapeutics, Dermira, Eli Lilly, F. Hoffmann-La Roche, Forward Pharma, G & W Laboratories, GlaxoSmithKline, Idera Pharmaceuticals, Incyte Corporation, Kadmon, kinetabio, KPI Therapeutics, Kyowa Hakko Kirin, LEO Pharma, Maruho, Merck, Mitsubishi Tanabe Pharma, Moleculin, MorphoSys, Novartis, Pfizer, Prism Pharma, Promius Pharma, Prothena Biosciences, Provectus Biopharmaceuticals, Sandoz, Sun Pharmaceuticals, Takeda Pharmaceuticals, Taro Pharmaceuticals, TFS Corp, Therapeutics, UCB, Valeant Pharmaceuticals, VBL Therapeutics, XenoPort, and Ziarco Pharma.  Market driver : Dominance of market by biologics  Market challenge - Physician's reluctance to prescribe biosimilars  Market trend - Advent of biologics with novel MOA and cell-based strategies  Inquire on the Report http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=635370http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=635370

5 Global Systemic Psoriasis Therapeutics Market 2016-2020  Key questions answered in this report  What will the market size be in 2020 and what will the growth rate be?  What are the key market trends?  What is driving this market?  What are the challenges to market growth?  Who are the key vendors in this market space?  What are the market opportunities and threats faced by the key vendors?  What are the strengths and weaknesses of the key vendors?  Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=635370http://www.rnrmarketresearch.com/contacts/discount?rname=635370

6 RNRMARKETRESEARCH.COMRNRMARKETRESEARCH.COM, An online repository of market research reports, offers in-depth analysis of over 5000 market segments. RNR market research library has syndicated reports by leading market research publishers across the globe. For more details contact : sales@rnrmarketresearch.Com / +18883915441 FOLLOW US RNR MARKET RESEARCH RNRMARKETRESEARCH.COM, An online repository of market research reports, offers in-depth analysis of over 5000 market segments. RNR market research library has syndicated reports by leading market research publishers across the globe. For more details contact : sales@rnrmarketresearch.Com / +18883915441 FOLLOW USsales@rnrmarketresearch.Com RNRMARKETRESEARCH.COMsales@rnrmarketresearch.Com Websitewww.rnrmarketresearch.com


Download ppt "Global Systemic Psoriasis Therapeutics Market 2016-2020 www.rnrmarketresearch.com WEBSITE Single User License: US$ 2500 No of Pages: 88 Corporate User."

Similar presentations


Ads by Google